- Home
- KROS vs BAND Comparison
KROS vs BAND Comparison
Compare KROS & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | BAND |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 427.6M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | KROS | BAND |
|---|---|---|
| Price | $21.39 | $15.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $22.20 | $20.80 |
| AVG Volume (30 Days) | ★ 980.1K | 206.2K |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | $246,718,000.00 | ★ $756,118,000.00 |
| Revenue This Year | $6,876.34 | $2.82 |
| Revenue Next Year | N/A | $15.10 |
| P/E Ratio | $13.55 | ★ N/A |
| Revenue Growth | ★ 37798.31 | 7.42 |
| 52 Week Low | $9.12 | $11.33 |
| 52 Week High | $22.55 | $19.88 |
Technical Indicators
Market Signals| Indicator | KROS | BAND |
|---|---|---|
| Relative Strength Index (RSI) | 65.16 | 54.38 |
| Support Level | $19.76 | $14.61 |
| Resistance Level | $21.75 | $15.20 |
| Average True Range (ATR) | 1.04 | 0.50 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 74.57 | 61.24 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.